- Published on
Emergency And Acute Medicine – Deep Vein Thrombosis
Core Description
A constant balance exists between intravascular clot formation and clot dissolution. Thrombosis develops when clot formation overwhelms fibrinolysis. Venous clots may be superficial (above the fascia) or deep; the latter constitutes deep vein thrombosis (DVT). Pulmonary embolism (PE) and DVT represent two ends of the same disease spectrum known as venous thromboembolism (VTE). DVT may involve upper or lower extremities and may be distal or proximal relative to the popliteal vein. The incidence is approximately 2 first-time VTE events per 1,000 person-years, increases with age, and is common among hospitalized medical and surgical patients. Diagnosis is more accurate with active surveillance rather than clinical suspicion alone.
Pediatric Considerations
DVT is uncommon in children. When present, evaluation for underlying hypercoagulable conditions is essential. Upper-extremity DVT in children is frequently associated with central venous catheters.
Etiology And Risk Factors
Thrombus formation is influenced by multiple interacting factors. Hypercoagulable states include malignancy, myeloproliferative disorders, nephrotic syndrome, sepsis, inflammatory conditions such as ulcerative colitis, increased estrogen states including pregnancy and exogenous hormones, antiphospholipid syndrome, inherited thrombophilias (protein C, protein S, antithrombin III deficiencies, factor V Leiden, prothrombin gene mutation), and autoimmune conditions.
Venous stasis occurs with prolonged bed rest, immobilization (casts), long-distance travel, paralysis from neurologic disease, congestive heart failure, and obesity.
Vascular injury or anatomic abnormalities include trauma, surgery, central venous lines (particularly for upper-extremity DVT), and May–Thurner syndrome.
Additional contributors include advanced age, certain medications (hydralazine, procainamide, phenothiazines), tobacco use, prior DVT or PE, and genetic predisposition. There is no universal consensus on which VTE patients require testing for inherited thrombophilias.
Pregnancy And Geriatric Considerations
Pregnancy increases DVT risk, particularly during the third trimester and up to two weeks postpartum. Advanced age independently increases DVT and PE risk, and presentations may be atypical in older adults.
Clinical Features
Typical findings include unilateral leg swelling, with a circumference difference greater than 1 cm considered significant, warmth, erythema, pain, tenderness, and sometimes a palpable cord. Superficial thrombophlebitis may present as a visible, tender, cord-like structure. Upper-extremity DVT causes arm swelling, warmth, and tenderness.
Severe presentations include phlegmasia cerulea dolens, characterized by a cold, tender, swollen, cyanotic limb with secondary arterial insufficiency and venous gangrene, and phlegmasia alba dolens, presenting with a cold, tender, pale limb due to arterial compromise.
Essential Evaluation
Assessment of pretest probability is central to DVT evaluation. Careful history and physical examination interpreted within the patient’s risk-factor profile guide diagnostic decisions, as individual signs and symptoms lack sufficient predictive value. Consider evaluation for occult malignancy when clinically appropriate, as VTE may be its initial manifestation.
Diagnostic Testing And Interpretation
D-dimer testing detects fibrin degradation products and is useful only when negative, allowing exclusion of DVT in low-risk patients. A positive result is nonspecific and mandates further imaging. ELISA-based D-dimer assays are the most validated, particularly when combined with pretest probability assessment.
Compression ultrasonography is the first-line diagnostic modality. Normal veins compress fully, whereas thrombosed veins do not. Duplex ultrasonography, combining B-mode imaging with Doppler, has sensitivity in the high 90% range. In high-risk patients with an initial negative ultrasound, repeat imaging or contrast venography is recommended.
Contrast venography, once the gold standard, is now rarely used because of invasiveness and associated complications. Other modalities such as radionuclide venography and impedance plethysmography are infrequently used.
Differential Diagnosis
Consider superficial thrombophlebitis, cellulitis, muscle or ligament tears, ruptured Baker cyst, bilateral edema from cardiac, hepatic, or renal disease, venous insufficiency, drug-induced edema, unilateral edema from abdominal masses or lymphedema, and postphlebitic syndrome.
Initial Stabilization
In cases of phlegmasia alba or cerulea dolens, establish IV access, administer supplemental oxygen, and obtain urgent vascular or surgical consultation.
Emergency Department Management
Systemic anticoagulation is the cornerstone of therapy in patients without contraindications, as PE develops in approximately 50% of untreated DVT. Options include unfractionated heparin, low-molecular-weight heparin (LMWH), fondaparinux, or adjusted-dose subcutaneous heparin. Carefully selected patients may be managed as outpatients.
Warfarin should be initiated only after heparin therapy to avoid transient hypercoagulability. Current evidence is insufficient to universally recommend newer oral anticoagulants in this setting.
Inferior vena cava filters are indicated when anticoagulation is contraindicated or when thromboembolism occurs despite adequate anticoagulation. Filters may also be considered in select high-risk scenarios, though randomized trials show no superiority over anticoagulation alone. Filters can also be placed in the superior vena cava for upper-extremity DVT.
Thrombolysis is rarely indicated because of increased bleeding risk but may be considered in select cases, particularly catheter-directed therapy for upper-extremity DVT. Thrombectomy may be appropriate for extensive disease after vascular consultation. Septic thrombophlebitis requires antibiotics and may necessitate surgical intervention.
Medication Management
Anticoagulation is continued until the INR is therapeutic for two consecutive days. Typical regimens include unfractionated heparin with a bolus followed by infusion titrated to aPTT, LMWH such as enoxaparin or tinzaparin, and warfarin initiated at standard dosing with INR monitoring. Treatment duration is generally at least three months and individualized thereafter.
Disposition And Follow-Up
Admission is indicated for patients unable to receive outpatient anticoagulation, those with concomitant PE, high bleeding risk, phlegmasia, or serious comorbidities.
Outpatient management is appropriate for reliable patients without serious comorbid disease who can administer LMWH and adhere to follow-up.
Vascular surgery consultation is warranted if arterial insufficiency is suspected or when considering vena cava filter placement.
Follow-Up Recommendations
Patients managed as outpatients require close monitoring of hematocrit, platelet count, and INR within several days. Repeat imaging is recommended when clinical suspicion remains high despite an initial negative ultrasound.
Key Clinical Lessons And Common Errors
A negative Homans sign does not exclude DVT. Always assess pretest probability using clinical judgment or validated tools such as the Wells score. In high-risk patients, proceed directly to imaging rather than relying on D-dimer testing. In moderate-risk patients with negative initial studies, arrange repeat evaluation within one week.
Core Description
A constant balance exists between intravascular clot formation and clot dissolution. Thrombosis develops when clot formation overwhelms fibrinolysis. Venous clots may be superficial (above the fascia) or deep; the latter constitutes deep vein thrombosis (DVT). Pulmonary embolism (PE) and DVT represent two ends of the same disease spectrum known as venous thromboembolism (VTE). DVT may involve upper or lower extremities and may be distal or proximal relative to the popliteal vein. The incidence is approximately 2 first-time VTE events per 1,000 person-years, increases with age, and is common among hospitalized medical and surgical patients. Diagnosis is more accurate with active surveillance rather than clinical suspicion alone.
Pediatric Considerations
DVT is uncommon in children. When present, evaluation for underlying hypercoagulable conditions is essential. Upper-extremity DVT in children is frequently associated with central venous catheters.
Etiology And Risk Factors
Thrombus formation is influenced by multiple interacting factors. Hypercoagulable states include malignancy, myeloproliferative disorders, nephrotic syndrome, sepsis, inflammatory conditions such as ulcerative colitis, increased estrogen states including pregnancy and exogenous hormones, antiphospholipid syndrome, inherited thrombophilias (protein C, protein S, antithrombin III deficiencies, factor V Leiden, prothrombin gene mutation), and autoimmune conditions.
Venous stasis occurs with prolonged bed rest, immobilization (casts), long-distance travel, paralysis from neurologic disease, congestive heart failure, and obesity.
Vascular injury or anatomic abnormalities include trauma, surgery, central venous lines (particularly for upper-extremity DVT), and May–Thurner syndrome.
Additional contributors include advanced age, certain medications (hydralazine, procainamide, phenothiazines), tobacco use, prior DVT or PE, and genetic predisposition. There is no universal consensus on which VTE patients require testing for inherited thrombophilias.
Pregnancy And Geriatric Considerations
Pregnancy increases DVT risk, particularly during the third trimester and up to two weeks postpartum. Advanced age independently increases DVT and PE risk, and presentations may be atypical in older adults.
Clinical Features
Typical findings include unilateral leg swelling, with a circumference difference greater than 1 cm considered significant, warmth, erythema, pain, tenderness, and sometimes a palpable cord. Superficial thrombophlebitis may present as a visible, tender, cord-like structure. Upper-extremity DVT causes arm swelling, warmth, and tenderness.
Severe presentations include phlegmasia cerulea dolens, characterized by a cold, tender, swollen, cyanotic limb with secondary arterial insufficiency and venous gangrene, and phlegmasia alba dolens, presenting with a cold, tender, pale limb due to arterial compromise.
Essential Evaluation
Assessment of pretest probability is central to DVT evaluation. Careful history and physical examination interpreted within the patient’s risk-factor profile guide diagnostic decisions, as individual signs and symptoms lack sufficient predictive value. Consider evaluation for occult malignancy when clinically appropriate, as VTE may be its initial manifestation.
Diagnostic Testing And Interpretation
D-dimer testing detects fibrin degradation products and is useful only when negative, allowing exclusion of DVT in low-risk patients. A positive result is nonspecific and mandates further imaging. ELISA-based D-dimer assays are the most validated, particularly when combined with pretest probability assessment.
Compression ultrasonography is the first-line diagnostic modality. Normal veins compress fully, whereas thrombosed veins do not. Duplex ultrasonography, combining B-mode imaging with Doppler, has sensitivity in the high 90% range. In high-risk patients with an initial negative ultrasound, repeat imaging or contrast venography is recommended.
Contrast venography, once the gold standard, is now rarely used because of invasiveness and associated complications. Other modalities such as radionuclide venography and impedance plethysmography are infrequently used.
Differential Diagnosis
Consider superficial thrombophlebitis, cellulitis, muscle or ligament tears, ruptured Baker cyst, bilateral edema from cardiac, hepatic, or renal disease, venous insufficiency, drug-induced edema, unilateral edema from abdominal masses or lymphedema, and postphlebitic syndrome.
Initial Stabilization
In cases of phlegmasia alba or cerulea dolens, establish IV access, administer supplemental oxygen, and obtain urgent vascular or surgical consultation.
Emergency Department Management
Systemic anticoagulation is the cornerstone of therapy in patients without contraindications, as PE develops in approximately 50% of untreated DVT. Options include unfractionated heparin, low-molecular-weight heparin (LMWH), fondaparinux, or adjusted-dose subcutaneous heparin. Carefully selected patients may be managed as outpatients.
Warfarin should be initiated only after heparin therapy to avoid transient hypercoagulability. Current evidence is insufficient to universally recommend newer oral anticoagulants in this setting.
Inferior vena cava filters are indicated when anticoagulation is contraindicated or when thromboembolism occurs despite adequate anticoagulation. Filters may also be considered in select high-risk scenarios, though randomized trials show no superiority over anticoagulation alone. Filters can also be placed in the superior vena cava for upper-extremity DVT.
Thrombolysis is rarely indicated because of increased bleeding risk but may be considered in select cases, particularly catheter-directed therapy for upper-extremity DVT. Thrombectomy may be appropriate for extensive disease after vascular consultation. Septic thrombophlebitis requires antibiotics and may necessitate surgical intervention.
Medication Management
Anticoagulation is continued until the INR is therapeutic for two consecutive days. Typical regimens include unfractionated heparin with a bolus followed by infusion titrated to aPTT, LMWH such as enoxaparin or tinzaparin, and warfarin initiated at standard dosing with INR monitoring. Treatment duration is generally at least three months and individualized thereafter.
Disposition And Follow-Up
Admission is indicated for patients unable to receive outpatient anticoagulation, those with concomitant PE, high bleeding risk, phlegmasia, or serious comorbidities.
Outpatient management is appropriate for reliable patients without serious comorbid disease who can administer LMWH and adhere to follow-up.
Vascular surgery consultation is warranted if arterial insufficiency is suspected or when considering vena cava filter placement.
Follow-Up Recommendations
Patients managed as outpatients require close monitoring of hematocrit, platelet count, and INR within several days. Repeat imaging is recommended when clinical suspicion remains high despite an initial negative ultrasound.
Key Clinical Lessons And Common Errors
A negative Homans sign does not exclude DVT. Always assess pretest probability using clinical judgment or validated tools such as the Wells score. In high-risk patients, proceed directly to imaging rather than relying on D-dimer testing. In moderate-risk patients with negative initial studies, arrange repeat evaluation within one week.
- Published on
Emergency And Acute Medicine – Decompression Sickness
Core Description
Decompression sickness is a multisystem disease caused by the formation of inert gas bubbles, primarily nitrogen, that escape from solution into body tissues and fluids during or after a reduction in ambient pressure.
Etiology And Pathophysiology
Decompression sickness occurs when nitrogen that has dissolved in body tissues under increased ambient pressure comes out of solution too rapidly during ascent. As ambient pressure increases, the partial pressure of inspired nitrogen rises, leading to progressive nitrogen absorption into tissues, particularly with longer exposure times. When ascent occurs too quickly, the pressure gradient overwhelms the body’s ability to eliminate nitrogen gradually. Tissues become supersaturated, and gas bubbles form.
According to Henry’s law, the amount of gas dissolved in a liquid is directly proportional to the partial pressure of that gas. Increased partial pressure results in greater gas dissolution, while decreased partial pressure causes gas to come out of solution. Nitrogen bubbles act as foreign bodies, triggering inflammatory and coagulation pathways, increasing vascular permeability, reducing intravascular volume, and causing hemoconcentration.
Clinical manifestations depend on bubble location. Bubbles may obstruct blood flow or lymphatics, leading to ischemia, infarction, or lymphedema, or they may cause mechanical tissue distention resulting in pain.
Risk Factors
Dive-related factors include greater depth, longer bottom time, multiple dives within a day, rapid ascent, and cold water exposure. Human factors include obesity, dehydration, pulmonary disease, and intercurrent illness. Proper use of dive tables or computers reduces but does not eliminate risk. Predive vigorous exercise may reduce risk. Approximately 50% of patients develop symptoms within 1 hour and 90% within 6 hours. Air travel after diving can precipitate decompression sickness because of reduced cabin pressure.
Clinical Presentation
Cutaneous Manifestations
Skin findings include scarlatiniform, erysipeloid, or mottled rashes. Cutis marmorata, a mottled appearance, often indicates more severe disease. A peau d’orange appearance may occur due to lymphatic obstruction.
Musculoskeletal Manifestations (The Bends)
Patients experience dull, deep muscular or joint pain, most commonly affecting the elbows and shoulders. Pain is typically not worsened by movement and is not reproducible with palpation.
Gastrointestinal Manifestations
Symptoms include nausea, vomiting, and abdominal pain.
Pulmonary Manifestations (The Chokes)
Pulmonary symptoms result from obstruction of pulmonary vasculature by gas bubbles and include acute respiratory distress, substernal chest pain or pressure, cough, dyspnea, and hypoxia.
Central Nervous System Manifestations
Neurologic symptoms include weakness, fatigue, numbness, paresthesias, agitation, headache, dizziness, vertigo, seizures, bladder or bowel incontinence, lethargy, and visual disturbances. The spinal cord, particularly the lower thoracic and lumbar regions, is most commonly affected.
Inner Ear Manifestations (The Staggers)
Vestibular involvement causes dizziness, vertigo, tinnitus, and nausea. These symptoms resemble inner ear barotrauma but carry a worse prognosis.
History And Physical Examination
A detailed dive history is essential, including depth, duration, ascent profile, surface intervals, and timing of symptom onset. Physical examination should be comprehensive, with particular attention to a detailed neurologic assessment to identify subtle or evolving deficits.
Essential Evaluation
Diagnosis is primarily clinical and based on recognition of risk factors and characteristic presentations. Neurologic findings should be carefully documented, including improvement or progression. Definitive diagnosis may be supported by a trial of pressure, as rapid symptom relief during recompression in a hyperbaric chamber is often diagnostic.
Diagnostic Testing And Interpretation
Laboratory studies may show elevated hematocrit due to hemoconcentration. Electrolytes, renal function, glucose, and urinalysis should be obtained, with increased urine specific gravity suggesting volume depletion. Arterial blood gas analysis and pulse oximetry are used to monitor oxygenation.
Imaging may include chest radiography to assess for pulmonary barotrauma or noncardiogenic pulmonary edema. Extremity radiographs may help exclude traumatic causes of pain. Head CT is indicated for altered mental status or focal neurologic deficits.
Differential Diagnosis
Consider musculoskeletal injury unrelated to bubble formation, inner or middle ear barotrauma, arterial gas embolism, cerebrovascular accident, and trauma.
Prehospital Management
Early recognition is critical, as postdive extremity pain may be misattributed to muscle strain and neurologic symptoms may be minimized by patients. If air evacuation is required, altitude should be limited to less than 1,000 feet or a pressurized aircraft should be used. In-water recompression is controversial, technically difficult, and requires extensive support.
Initial Stabilization
Airway, breathing, and circulation should be managed promptly. Administer 100% normobaric oxygen via mask or endotracheal tube to enhance nitrogen elimination, reduce bubble size, and improve tissue oxygenation. Maintain the patient in a supine position to minimize cerebral involvement. Early recompression in a hyperbaric chamber is essential.
Emergency Department Management
Administer intravenous 0.9% normal saline to correct dehydration and maintain urine output of 1–2 mL/kg/hour. Dehydration is common due to pressure-induced diuresis, exertion, dry compressed air breathing, and capillary leak. Adequate hydration promotes nitrogen elimination.
Arrange urgent hyperbaric oxygen recompression therapy and transfer to the nearest facility. Insert a prophylactic chest tube for known pneumothorax to prevent tension pneumothorax during recompression. Inflate endotracheal and Foley catheter balloons with saline or water to prevent compression-related damage.
Provide analgesics and antiemetics as needed. Diazepam may be used for severe vertigo. Adjunctive NSAIDs or heliox may reduce the number of recompression treatments required. Consultation with Divers Alert Network is recommended for expert guidance and referral.
Disposition And Follow-Up
All patients with suspected or confirmed decompression sickness should be referred for hyperbaric therapy. Stable patients with mild symptoms may be discharged after treatment. Patients should avoid air travel after treatment, as reduced ambient pressure may worsen symptoms.
Follow-Up Recommendations
Ensure hyperbaric medicine follow-up and reinforce diving safety counseling.
Key Clinical Lessons And Common Errors
Musculoskeletal decompression sickness can be difficult to distinguish from benign musculoskeletal pain. Significant fatigue alone may represent decompression sickness. Even mild or resolving symptoms warrant hyperbaric recompression therapy. Do not delay recompression for laboratory testing or imaging when decompression sickness is the likely diagnosis. In-water recompression should be avoided.
Core Description
Decompression sickness is a multisystem disease caused by the formation of inert gas bubbles, primarily nitrogen, that escape from solution into body tissues and fluids during or after a reduction in ambient pressure.
Etiology And Pathophysiology
Decompression sickness occurs when nitrogen that has dissolved in body tissues under increased ambient pressure comes out of solution too rapidly during ascent. As ambient pressure increases, the partial pressure of inspired nitrogen rises, leading to progressive nitrogen absorption into tissues, particularly with longer exposure times. When ascent occurs too quickly, the pressure gradient overwhelms the body’s ability to eliminate nitrogen gradually. Tissues become supersaturated, and gas bubbles form.
According to Henry’s law, the amount of gas dissolved in a liquid is directly proportional to the partial pressure of that gas. Increased partial pressure results in greater gas dissolution, while decreased partial pressure causes gas to come out of solution. Nitrogen bubbles act as foreign bodies, triggering inflammatory and coagulation pathways, increasing vascular permeability, reducing intravascular volume, and causing hemoconcentration.
Clinical manifestations depend on bubble location. Bubbles may obstruct blood flow or lymphatics, leading to ischemia, infarction, or lymphedema, or they may cause mechanical tissue distention resulting in pain.
Risk Factors
Dive-related factors include greater depth, longer bottom time, multiple dives within a day, rapid ascent, and cold water exposure. Human factors include obesity, dehydration, pulmonary disease, and intercurrent illness. Proper use of dive tables or computers reduces but does not eliminate risk. Predive vigorous exercise may reduce risk. Approximately 50% of patients develop symptoms within 1 hour and 90% within 6 hours. Air travel after diving can precipitate decompression sickness because of reduced cabin pressure.
Clinical Presentation
Cutaneous Manifestations
Skin findings include scarlatiniform, erysipeloid, or mottled rashes. Cutis marmorata, a mottled appearance, often indicates more severe disease. A peau d’orange appearance may occur due to lymphatic obstruction.
Musculoskeletal Manifestations (The Bends)
Patients experience dull, deep muscular or joint pain, most commonly affecting the elbows and shoulders. Pain is typically not worsened by movement and is not reproducible with palpation.
Gastrointestinal Manifestations
Symptoms include nausea, vomiting, and abdominal pain.
Pulmonary Manifestations (The Chokes)
Pulmonary symptoms result from obstruction of pulmonary vasculature by gas bubbles and include acute respiratory distress, substernal chest pain or pressure, cough, dyspnea, and hypoxia.
Central Nervous System Manifestations
Neurologic symptoms include weakness, fatigue, numbness, paresthesias, agitation, headache, dizziness, vertigo, seizures, bladder or bowel incontinence, lethargy, and visual disturbances. The spinal cord, particularly the lower thoracic and lumbar regions, is most commonly affected.
Inner Ear Manifestations (The Staggers)
Vestibular involvement causes dizziness, vertigo, tinnitus, and nausea. These symptoms resemble inner ear barotrauma but carry a worse prognosis.
History And Physical Examination
A detailed dive history is essential, including depth, duration, ascent profile, surface intervals, and timing of symptom onset. Physical examination should be comprehensive, with particular attention to a detailed neurologic assessment to identify subtle or evolving deficits.
Essential Evaluation
Diagnosis is primarily clinical and based on recognition of risk factors and characteristic presentations. Neurologic findings should be carefully documented, including improvement or progression. Definitive diagnosis may be supported by a trial of pressure, as rapid symptom relief during recompression in a hyperbaric chamber is often diagnostic.
Diagnostic Testing And Interpretation
Laboratory studies may show elevated hematocrit due to hemoconcentration. Electrolytes, renal function, glucose, and urinalysis should be obtained, with increased urine specific gravity suggesting volume depletion. Arterial blood gas analysis and pulse oximetry are used to monitor oxygenation.
Imaging may include chest radiography to assess for pulmonary barotrauma or noncardiogenic pulmonary edema. Extremity radiographs may help exclude traumatic causes of pain. Head CT is indicated for altered mental status or focal neurologic deficits.
Differential Diagnosis
Consider musculoskeletal injury unrelated to bubble formation, inner or middle ear barotrauma, arterial gas embolism, cerebrovascular accident, and trauma.
Prehospital Management
Early recognition is critical, as postdive extremity pain may be misattributed to muscle strain and neurologic symptoms may be minimized by patients. If air evacuation is required, altitude should be limited to less than 1,000 feet or a pressurized aircraft should be used. In-water recompression is controversial, technically difficult, and requires extensive support.
Initial Stabilization
Airway, breathing, and circulation should be managed promptly. Administer 100% normobaric oxygen via mask or endotracheal tube to enhance nitrogen elimination, reduce bubble size, and improve tissue oxygenation. Maintain the patient in a supine position to minimize cerebral involvement. Early recompression in a hyperbaric chamber is essential.
Emergency Department Management
Administer intravenous 0.9% normal saline to correct dehydration and maintain urine output of 1–2 mL/kg/hour. Dehydration is common due to pressure-induced diuresis, exertion, dry compressed air breathing, and capillary leak. Adequate hydration promotes nitrogen elimination.
Arrange urgent hyperbaric oxygen recompression therapy and transfer to the nearest facility. Insert a prophylactic chest tube for known pneumothorax to prevent tension pneumothorax during recompression. Inflate endotracheal and Foley catheter balloons with saline or water to prevent compression-related damage.
Provide analgesics and antiemetics as needed. Diazepam may be used for severe vertigo. Adjunctive NSAIDs or heliox may reduce the number of recompression treatments required. Consultation with Divers Alert Network is recommended for expert guidance and referral.
Disposition And Follow-Up
All patients with suspected or confirmed decompression sickness should be referred for hyperbaric therapy. Stable patients with mild symptoms may be discharged after treatment. Patients should avoid air travel after treatment, as reduced ambient pressure may worsen symptoms.
Follow-Up Recommendations
Ensure hyperbaric medicine follow-up and reinforce diving safety counseling.
Key Clinical Lessons And Common Errors
Musculoskeletal decompression sickness can be difficult to distinguish from benign musculoskeletal pain. Significant fatigue alone may represent decompression sickness. Even mild or resolving symptoms warrant hyperbaric recompression therapy. Do not delay recompression for laboratory testing or imaging when decompression sickness is the likely diagnosis. In-water recompression should be avoided.
- Published on
Emergency And Acute Medicine – Dacryocystitis And Dacryoadenitis
Core Description
Dacryoadenitis and dacryocystitis are inflammatory disorders of the lacrimal system. Dacryoadenitis refers to inflammation or infection of the lacrimal gland, which produces tears. Dacryocystitis is a suppurative infection of the lacrimal drainage system, specifically the lacrimal sac, usually occurring in the setting of ductal obstruction. Dacryoadenitis may be inflammatory or infectious and can result from contiguous spread or systemic disease, whereas dacryocystitis is almost always infectious due to tear stasis within an obstructed duct.
Epidemiology
Dacryoadenitis is uncommon and is more frequently seen on the left side. Acquired cases are rare. Dacryocystitis is more common, most often affecting adult females older than 30 years, though it may also present in infants.
Etiology Of Dacryoadenitis
Dacryoadenitis is most commonly associated with systemic inflammatory and autoimmune conditions, including Sjögren syndrome, sarcoidosis, Crohn disease, and lacrimal gland tumors. Infectious causes may be primary or secondary to contiguous spread from bacterial conjunctivitis or periorbital cellulitis. Acute suppurative dacryoadenitis in adults is most often caused by Staphylococcus aureus, streptococci, Chlamydia trachomatis, and Neisseria gonorrhoeae. Chronic dacryoadenitis is more commonly related to nasal flora rather than ocular organisms.
Pediatric Considerations In Dacryoadenitis
In children, viral causes predominate, including mumps, measles, Epstein–Barr virus, cytomegalovirus, coxsackievirus, and varicella-zoster virus. A slowly enlarging lacrimal gland mass in children may represent a dermoid cyst rather than infection.
Etiology Of Dacryocystitis
Under normal conditions, tears drain through the lacrimal duct into the lacrimal sac and then into the middle turbinate and sinuses via a pumping mechanism. Dacryocystitis develops when the duct becomes partially or completely obstructed. In adults, chronic inflammation related to ethmoid sinusitis is a common underlying cause, though trauma, dacryoliths, nasal or sinus surgery, or any local obstructive process may contribute. Obstruction leads to tear stasis, bacterial overgrowth, and infection. The infection may be recurrent or chronic. Sinus flora predominate over ocular flora, with Staphylococcus aureus being the most common organism. Complications include draining fistulae, recurrent conjunctivitis, abscess formation, and orbital cellulitis.
Pediatric Considerations In Dacryocystitis
Congenital dacryocystitis typically presents in infancy due to dacryocystoceles and carries high morbidity and mortality, often from systemic spread of infection. The most common pathogen in this population is Streptococcus pneumoniae.
Clinical Presentation
Both dacryoadenitis and dacryocystitis usually present with unilateral eye pain, redness, and swelling.
Dacryoadenitis Symptoms And Signs
Patients may develop acute or indolent swelling and erythema of the upper eyelid, with maximal tenderness in the temporal portion beneath the orbital rim, producing an S-shaped eyelid. A palpable mass may be present. Associated findings include conjunctival injection, discharge, chemosis, variable tear production, ipsilateral preauricular lymphadenopathy, and surrounding cellulitis. Systemic toxicity may occur. Visual acuity, slit-lamp examination, and funduscopic findings are typically normal, though globe displacement may cause visual distortion. Chronic dacryoadenitis presents as a slowly progressive, painless swelling.
Alert: Rapidly assess for possible spread from gonococcal conjunctivitis, as morbidity is high, visual loss is likely, systemic illness is common, and treatment differs significantly.
Dacryocystitis Symptoms And Signs
Dacryocystitis presents as an acutely inflamed, localized mass inferior and medial to the inner canthus. Epiphora is the hallmark symptom due to tear outflow obstruction. Applying pressure to the mass may express purulent material from the punctum, which is diagnostically helpful. Lower eyelid cellulitis may occur. Fever is usually low grade, and patients rarely appear toxic.
Essential Evaluation
A complete ocular examination is required, including visual acuity, extraocular movements, slit-lamp examination, funduscopic examination, eyelid eversion, and nasal inspection.
Pediatric Alert: Carefully assess for extension to orbital cellulitis or meningitis.
Diagnostic Testing And Interpretation
Purulent material should be sent for Gram stain, culture, and sensitivity testing. Chocolate agar should be used if gonococcal infection is suspected. CBC and blood cultures may be obtained when systemic infection is suspected. CT imaging of the orbit and sinuses is indicated to assess for deep tissue involvement, recurrent dacryoadenitis, or suspected orbital extension, particularly in children or high-risk patients.
Differential Diagnosis
For dacryoadenitis, consider autoimmune disease, lacrimal gland tumors, hordeolum, periorbital or orbital cellulitis, severe blepharitis, insect bites, and traumatic injury.
For dacryocystitis, consider insect bites, trauma, acute ethmoid sinusitis, periorbital cellulitis, and acute conjunctivitis.
Emergency Department Management
Early recognition and treatment are essential to prevent local extension and systemic infection. Topical antibiotics may be used to prevent secondary conjunctivitis.
Management Of Dacryoadenitis
Supportive care includes cool compresses and nonsteroidal analgesics. Viral causes are typically self-limited. Bacterial infections require antibiotics, with oral agents such as cephalexin or amoxicillin/clavulanate for mild cases and intravenous therapy such as cefazolin or ticarcillin/clavulanate for severe infections. Administer tetanus toxoid when indicated. Incision and drainage are rarely required and should be performed only in severe cases with ophthalmology or facial surgery consultation.
In children, use cool compresses and analgesics; if the cause is unclear, treat empirically with antibiotics as in adults.
Management Of Dacryocystitis
Drainage of the infected lacrimal sac is essential. Warm compresses and gentle massage may relieve obstruction. Intranasal vasoconstrictors can facilitate drainage. Incision and drainage should be avoided in the ED when possible, as it increases the risk of fistula formation. Duct instrumentation is contraindicated in the acute setting due to risk of permanent scarring and stenosis. Use topical ophthalmic antibiotics to prevent conjunctivitis and systemic antibiotics to treat infection and prevent spread. Administer intravenous antibiotics for febrile or severe infections. Provide adequate analgesia.
Pediatric Management Considerations
Newborns typically respond to massage and topical antibiotics in approximately 95% of cases. Failure to resolve within the first year may require ophthalmologic probing. Children younger than 4 years with dacryocystitis are at increased risk for Haemophilus influenzae infection if not fully immunized. Afebrile, well-appearing children with reliable caregivers may be treated with oral cefaclor or amoxicillin/clavulanate, while acutely ill children require intravenous cefuroxime due to the high risk of bacteremia, septicemia, and meningitis.
Pharmacologic Therapy
Recommended agents include amoxicillin/clavulanate, cefaclor, cefazolin, cefuroxime, cephalexin, erythromycin ophthalmic ointment, trimethoprim–polymyxin ophthalmic ointment, and ticarcillin/clavulanate, dosed appropriately for adults and children. Intranasal tetracaine and phenylephrine may be used to facilitate drainage.
Disposition And Follow-Up
Hospital admission is indicated for febrile or toxic adults, immunocompromised patients, extensive cellulitis, suspected deep tissue or meningeal spread, and high-risk pediatric cases, including unimmunized children or those without reliable follow-up. Prompt ophthalmology referral is required for all cases. Patients with dacryocystitis require confirmation of complete drainage and assessment for definitive intervention to prevent recurrence before discharge.
Key Clinical Lessons And Common Errors
In any patient with a red eye and eyelid swelling, the lacrimal system must be carefully examined. Skin incision and drainage of dacryocystitis should be avoided whenever possible to prevent fistula formation; intranasal vasoconstrictors are preferred to facilitate drainage.
Core Description
Dacryoadenitis and dacryocystitis are inflammatory disorders of the lacrimal system. Dacryoadenitis refers to inflammation or infection of the lacrimal gland, which produces tears. Dacryocystitis is a suppurative infection of the lacrimal drainage system, specifically the lacrimal sac, usually occurring in the setting of ductal obstruction. Dacryoadenitis may be inflammatory or infectious and can result from contiguous spread or systemic disease, whereas dacryocystitis is almost always infectious due to tear stasis within an obstructed duct.
Epidemiology
Dacryoadenitis is uncommon and is more frequently seen on the left side. Acquired cases are rare. Dacryocystitis is more common, most often affecting adult females older than 30 years, though it may also present in infants.
Etiology Of Dacryoadenitis
Dacryoadenitis is most commonly associated with systemic inflammatory and autoimmune conditions, including Sjögren syndrome, sarcoidosis, Crohn disease, and lacrimal gland tumors. Infectious causes may be primary or secondary to contiguous spread from bacterial conjunctivitis or periorbital cellulitis. Acute suppurative dacryoadenitis in adults is most often caused by Staphylococcus aureus, streptococci, Chlamydia trachomatis, and Neisseria gonorrhoeae. Chronic dacryoadenitis is more commonly related to nasal flora rather than ocular organisms.
Pediatric Considerations In Dacryoadenitis
In children, viral causes predominate, including mumps, measles, Epstein–Barr virus, cytomegalovirus, coxsackievirus, and varicella-zoster virus. A slowly enlarging lacrimal gland mass in children may represent a dermoid cyst rather than infection.
Etiology Of Dacryocystitis
Under normal conditions, tears drain through the lacrimal duct into the lacrimal sac and then into the middle turbinate and sinuses via a pumping mechanism. Dacryocystitis develops when the duct becomes partially or completely obstructed. In adults, chronic inflammation related to ethmoid sinusitis is a common underlying cause, though trauma, dacryoliths, nasal or sinus surgery, or any local obstructive process may contribute. Obstruction leads to tear stasis, bacterial overgrowth, and infection. The infection may be recurrent or chronic. Sinus flora predominate over ocular flora, with Staphylococcus aureus being the most common organism. Complications include draining fistulae, recurrent conjunctivitis, abscess formation, and orbital cellulitis.
Pediatric Considerations In Dacryocystitis
Congenital dacryocystitis typically presents in infancy due to dacryocystoceles and carries high morbidity and mortality, often from systemic spread of infection. The most common pathogen in this population is Streptococcus pneumoniae.
Clinical Presentation
Both dacryoadenitis and dacryocystitis usually present with unilateral eye pain, redness, and swelling.
Dacryoadenitis Symptoms And Signs
Patients may develop acute or indolent swelling and erythema of the upper eyelid, with maximal tenderness in the temporal portion beneath the orbital rim, producing an S-shaped eyelid. A palpable mass may be present. Associated findings include conjunctival injection, discharge, chemosis, variable tear production, ipsilateral preauricular lymphadenopathy, and surrounding cellulitis. Systemic toxicity may occur. Visual acuity, slit-lamp examination, and funduscopic findings are typically normal, though globe displacement may cause visual distortion. Chronic dacryoadenitis presents as a slowly progressive, painless swelling.
Alert: Rapidly assess for possible spread from gonococcal conjunctivitis, as morbidity is high, visual loss is likely, systemic illness is common, and treatment differs significantly.
Dacryocystitis Symptoms And Signs
Dacryocystitis presents as an acutely inflamed, localized mass inferior and medial to the inner canthus. Epiphora is the hallmark symptom due to tear outflow obstruction. Applying pressure to the mass may express purulent material from the punctum, which is diagnostically helpful. Lower eyelid cellulitis may occur. Fever is usually low grade, and patients rarely appear toxic.
Essential Evaluation
A complete ocular examination is required, including visual acuity, extraocular movements, slit-lamp examination, funduscopic examination, eyelid eversion, and nasal inspection.
Pediatric Alert: Carefully assess for extension to orbital cellulitis or meningitis.
Diagnostic Testing And Interpretation
Purulent material should be sent for Gram stain, culture, and sensitivity testing. Chocolate agar should be used if gonococcal infection is suspected. CBC and blood cultures may be obtained when systemic infection is suspected. CT imaging of the orbit and sinuses is indicated to assess for deep tissue involvement, recurrent dacryoadenitis, or suspected orbital extension, particularly in children or high-risk patients.
Differential Diagnosis
For dacryoadenitis, consider autoimmune disease, lacrimal gland tumors, hordeolum, periorbital or orbital cellulitis, severe blepharitis, insect bites, and traumatic injury.
For dacryocystitis, consider insect bites, trauma, acute ethmoid sinusitis, periorbital cellulitis, and acute conjunctivitis.
Emergency Department Management
Early recognition and treatment are essential to prevent local extension and systemic infection. Topical antibiotics may be used to prevent secondary conjunctivitis.
Management Of Dacryoadenitis
Supportive care includes cool compresses and nonsteroidal analgesics. Viral causes are typically self-limited. Bacterial infections require antibiotics, with oral agents such as cephalexin or amoxicillin/clavulanate for mild cases and intravenous therapy such as cefazolin or ticarcillin/clavulanate for severe infections. Administer tetanus toxoid when indicated. Incision and drainage are rarely required and should be performed only in severe cases with ophthalmology or facial surgery consultation.
In children, use cool compresses and analgesics; if the cause is unclear, treat empirically with antibiotics as in adults.
Management Of Dacryocystitis
Drainage of the infected lacrimal sac is essential. Warm compresses and gentle massage may relieve obstruction. Intranasal vasoconstrictors can facilitate drainage. Incision and drainage should be avoided in the ED when possible, as it increases the risk of fistula formation. Duct instrumentation is contraindicated in the acute setting due to risk of permanent scarring and stenosis. Use topical ophthalmic antibiotics to prevent conjunctivitis and systemic antibiotics to treat infection and prevent spread. Administer intravenous antibiotics for febrile or severe infections. Provide adequate analgesia.
Pediatric Management Considerations
Newborns typically respond to massage and topical antibiotics in approximately 95% of cases. Failure to resolve within the first year may require ophthalmologic probing. Children younger than 4 years with dacryocystitis are at increased risk for Haemophilus influenzae infection if not fully immunized. Afebrile, well-appearing children with reliable caregivers may be treated with oral cefaclor or amoxicillin/clavulanate, while acutely ill children require intravenous cefuroxime due to the high risk of bacteremia, septicemia, and meningitis.
Pharmacologic Therapy
Recommended agents include amoxicillin/clavulanate, cefaclor, cefazolin, cefuroxime, cephalexin, erythromycin ophthalmic ointment, trimethoprim–polymyxin ophthalmic ointment, and ticarcillin/clavulanate, dosed appropriately for adults and children. Intranasal tetracaine and phenylephrine may be used to facilitate drainage.
Disposition And Follow-Up
Hospital admission is indicated for febrile or toxic adults, immunocompromised patients, extensive cellulitis, suspected deep tissue or meningeal spread, and high-risk pediatric cases, including unimmunized children or those without reliable follow-up. Prompt ophthalmology referral is required for all cases. Patients with dacryocystitis require confirmation of complete drainage and assessment for definitive intervention to prevent recurrence before discharge.
Key Clinical Lessons And Common Errors
In any patient with a red eye and eyelid swelling, the lacrimal system must be carefully examined. Skin incision and drainage of dacryocystitis should be avoided whenever possible to prevent fistula formation; intranasal vasoconstrictors are preferred to facilitate drainage.
- Published on
Emergency and Acute Medicine – Cardiogenic Shock
Core Concept
Cardiogenic shock is defined by sustained hypotension and systemic hypoperfusion resulting from primary cardiac pump failure despite adequate intravascular volume and left ventricular filling pressures. It remains the leading cause of in-hospital mortality in patients with acute myocardial infarction (AMI). Approximately 5–8% of patients with STEMI develop cardiogenic shock. Pathophysiology includes severe LV dysfunction (often ≥40% infarction), infarction superimposed on chronic LV disease, reinfarction, mechanical complications (acute mitral regurgitation, ventricular septal rupture, free wall rupture with tamponade), and right ventricular infarction. A systemic inflammatory response with excess nitric oxide may worsen vasodilation and myocardial depression. Early β-blocker, ACE inhibitor, or aggressive diuretic use may contribute to shock development in vulnerable patients.
Underlying Causes
Acute myocardial infarction
Sepsis
Myocarditis
Myocardial contusion
Valvular heart disease
Dilated or ischemic cardiomyopathy
Left atrial myxoma
Drug toxicity (β-blockers, calcium channel blockers, anthracyclines)
Clinical Presentation
Airway and breathing findings include early tachypnea and labored respirations progressing to respiratory failure, diffuse crackles or wheezing, and hypoxia. Circulatory findings include systolic blood pressure <90 mm hg or a ≥30 drop from baseline, tachycardia, weak pulses, oliguria (<20 ml />r), cyanosis, pallor, diaphoresis, altered mental status, and hypothermia. Jugular venous distention is common. Cardiac findings may include ischemic chest pain, apical systolic murmur (acute MR), gallop rhythm (S3 indicating severe LV dysfunction; S4 common in AMI with sinus rhythm), or a systolic click suggesting papillary muscle or chordal rupture. GI symptoms include epigastric pain, nausea, and vomiting. Neurologic findings include obtundation or confusion. History should be obtained rapidly from patient, family, or EMS, focusing on cardiac risk factors and medication use. Physical exam emphasizes differentiation from distributive or hypovolemic shock; cool extremities with elevated JVP favor cardiogenic shock.
Initial Evaluation Priorities
Diagnostic studies help define the extent of myocardial injury and identify candidates for urgent catheterization or surgery.
Key Diagnostics
Electrocardiogram may show ST-elevation MI, NSTEMI patterns, dysrhythmias, or LV hypertrophy; a normal ECG does not exclude AMI. Laboratory tests include troponin, CK/CK-MB, BNP (diagnostic and prognostic), electrolytes, renal function (acute kidney injury strongly predicts mortality), CBC, and relevant drug levels (e.g., digoxin). Chest radiograph may demonstrate pulmonary edema, pleural effusions, cardiomegaly, pneumonia, pneumothorax, or pericardial effusion. Emergent transthoracic echocardiography with Doppler is critical to assess LV function, wall-motion abnormalities, acute MR or septal defects, RV size and function (RV infarction vs pulmonary embolism), and pericardial tamponade.
Important Differentials
Obstructive shock: tension pneumothorax, cardiac tamponade, pulmonary embolism, air embolism, esophageal rupture
Distributive shock: sepsis, anaphylaxis, adrenal crisis, neurogenic shock
Hypovolemic shock: hemorrhage, dehydration, GI losses, burns
Prehospital Management
Immediate airway, oxygen, IV access, and monitoring. Consider cautious fluid bolus if lungs are clear. Administer aspirin. Use nitroglycerin or morphine for ischemic pain only if hypotension is absent. Transport AMI patients to centers with 24-hour revascularization capability.
Early Stabilization in the ED
Secure airway and provide ventilatory support as needed; etomidate is preferred for induction due to minimal hemodynamic effect. Establish two large-bore IV lines and continuous cardiac monitoring. Administer a cautious fluid challenge (100–250 mL NS) if no pulmonary congestion. Insert Foley catheter for urine output monitoring.
Definitive Emergency Management
For AMI, initiate aspirin and heparin, consider thrombolysis if PCI or CABG unavailable, and use GP IIb/IIIa inhibitors when appropriate prior to PCI. Norepinephrine is the first-line vasopressor for hypotension; dopamine may be used if norepinephrine is unavailable. In normotensive patients with low cardiac output, dobutamine may be added, sometimes combined with nitroprusside in acute MR. Milrinone may be considered as adjunctive in selected cases. Pulmonary edema in normotensive patients may be treated with nitroglycerin infusion or diuretics. Early cardiology consultation is essential; intra-aortic balloon pump support can improve survival in experienced centers. Early revascularization is the single most effective life-saving intervention.
Common Medications
Dobutamine 3–5 μg/kg/min IV, titrate as needed
Dopamine 3–5 μg/kg/min IV, titrate as needed
Norepinephrine starting at 2 μg/min IV, titrate to MAP
Nitroglycerin 10–20 μg/min IV (non-PVC tubing)
Milrinone loading 50 μg/kg, then 0.375–0.75 μg/kg/min IV
Furosemide 40–80 mg IV (if appropriate)
Nitroprusside 0.3 μg/kg/min IV, titrate cautiously
Disposition
All patients with cardiogenic shock require admission to an intensive care unit.
Clinical Takeaways
Cardiogenic shock is the most common cause of death in hospitalized AMI patients. Early identification of preshock states, rapid hemodynamic support, and prompt revascularization dramatically improve outcomes.
Core Concept
Cardiogenic shock is defined by sustained hypotension and systemic hypoperfusion resulting from primary cardiac pump failure despite adequate intravascular volume and left ventricular filling pressures. It remains the leading cause of in-hospital mortality in patients with acute myocardial infarction (AMI). Approximately 5–8% of patients with STEMI develop cardiogenic shock. Pathophysiology includes severe LV dysfunction (often ≥40% infarction), infarction superimposed on chronic LV disease, reinfarction, mechanical complications (acute mitral regurgitation, ventricular septal rupture, free wall rupture with tamponade), and right ventricular infarction. A systemic inflammatory response with excess nitric oxide may worsen vasodilation and myocardial depression. Early β-blocker, ACE inhibitor, or aggressive diuretic use may contribute to shock development in vulnerable patients.
Underlying Causes
Acute myocardial infarction
Sepsis
Myocarditis
Myocardial contusion
Valvular heart disease
Dilated or ischemic cardiomyopathy
Left atrial myxoma
Drug toxicity (β-blockers, calcium channel blockers, anthracyclines)
Clinical Presentation
Airway and breathing findings include early tachypnea and labored respirations progressing to respiratory failure, diffuse crackles or wheezing, and hypoxia. Circulatory findings include systolic blood pressure <90 mm hg or a ≥30 drop from baseline, tachycardia, weak pulses, oliguria (<20 ml />r), cyanosis, pallor, diaphoresis, altered mental status, and hypothermia. Jugular venous distention is common. Cardiac findings may include ischemic chest pain, apical systolic murmur (acute MR), gallop rhythm (S3 indicating severe LV dysfunction; S4 common in AMI with sinus rhythm), or a systolic click suggesting papillary muscle or chordal rupture. GI symptoms include epigastric pain, nausea, and vomiting. Neurologic findings include obtundation or confusion. History should be obtained rapidly from patient, family, or EMS, focusing on cardiac risk factors and medication use. Physical exam emphasizes differentiation from distributive or hypovolemic shock; cool extremities with elevated JVP favor cardiogenic shock.
Initial Evaluation Priorities
Diagnostic studies help define the extent of myocardial injury and identify candidates for urgent catheterization or surgery.
Key Diagnostics
Electrocardiogram may show ST-elevation MI, NSTEMI patterns, dysrhythmias, or LV hypertrophy; a normal ECG does not exclude AMI. Laboratory tests include troponin, CK/CK-MB, BNP (diagnostic and prognostic), electrolytes, renal function (acute kidney injury strongly predicts mortality), CBC, and relevant drug levels (e.g., digoxin). Chest radiograph may demonstrate pulmonary edema, pleural effusions, cardiomegaly, pneumonia, pneumothorax, or pericardial effusion. Emergent transthoracic echocardiography with Doppler is critical to assess LV function, wall-motion abnormalities, acute MR or septal defects, RV size and function (RV infarction vs pulmonary embolism), and pericardial tamponade.
Important Differentials
Obstructive shock: tension pneumothorax, cardiac tamponade, pulmonary embolism, air embolism, esophageal rupture
Distributive shock: sepsis, anaphylaxis, adrenal crisis, neurogenic shock
Hypovolemic shock: hemorrhage, dehydration, GI losses, burns
Prehospital Management
Immediate airway, oxygen, IV access, and monitoring. Consider cautious fluid bolus if lungs are clear. Administer aspirin. Use nitroglycerin or morphine for ischemic pain only if hypotension is absent. Transport AMI patients to centers with 24-hour revascularization capability.
Early Stabilization in the ED
Secure airway and provide ventilatory support as needed; etomidate is preferred for induction due to minimal hemodynamic effect. Establish two large-bore IV lines and continuous cardiac monitoring. Administer a cautious fluid challenge (100–250 mL NS) if no pulmonary congestion. Insert Foley catheter for urine output monitoring.
Definitive Emergency Management
For AMI, initiate aspirin and heparin, consider thrombolysis if PCI or CABG unavailable, and use GP IIb/IIIa inhibitors when appropriate prior to PCI. Norepinephrine is the first-line vasopressor for hypotension; dopamine may be used if norepinephrine is unavailable. In normotensive patients with low cardiac output, dobutamine may be added, sometimes combined with nitroprusside in acute MR. Milrinone may be considered as adjunctive in selected cases. Pulmonary edema in normotensive patients may be treated with nitroglycerin infusion or diuretics. Early cardiology consultation is essential; intra-aortic balloon pump support can improve survival in experienced centers. Early revascularization is the single most effective life-saving intervention.
Common Medications
Dobutamine 3–5 μg/kg/min IV, titrate as needed
Dopamine 3–5 μg/kg/min IV, titrate as needed
Norepinephrine starting at 2 μg/min IV, titrate to MAP
Nitroglycerin 10–20 μg/min IV (non-PVC tubing)
Milrinone loading 50 μg/kg, then 0.375–0.75 μg/kg/min IV
Furosemide 40–80 mg IV (if appropriate)
Nitroprusside 0.3 μg/kg/min IV, titrate cautiously
Disposition
All patients with cardiogenic shock require admission to an intensive care unit.
Clinical Takeaways
Cardiogenic shock is the most common cause of death in hospitalized AMI patients. Early identification of preshock states, rapid hemodynamic support, and prompt revascularization dramatically improve outcomes.
- Published on
Emergency and Acute Medicine – Caustic Ingestion
Core Concept
Caustic ingestion causes chemical injury to tissues through acid or alkali exposure. Alkalis dissociate in water to form hydroxyl (OH⁻) ions, producing liquefaction necrosis that primarily damages the esophagus, though gastric injury can occur. Injury progresses from superficial hyperemia and mucosal edema to blistering, ulceration, full-thickness necrosis, perforation, and late fibrosis with esophageal strictures. Alkalis typically do not cause systemic toxicity.
Acids dissociate to form hydrogen (H⁺) ions, leading to coagulation necrosis with eschar formation. Due to rapid esophageal transit, acids mainly injure the stomach, producing edema, inflammation, hemorrhage, necrosis, perforation, and late gastric outlet obstruction. Acids are well absorbed and may cause hemolysis and systemic metabolic acidosis.
Etiologic Sources
Injuries result from direct chemical exposure to acids or alkalis, commonly found in household and industrial products. These include ammonia hydroxide, sodium hydroxide (drain and oven cleaners), sodium hypochlorite (bleach), sulfuric acid (car batteries), hydrochloric acid (toilet cleaners), hydrofluoric acid (glass etching and microchip industries), phenol, formaldehyde, iodine, detergents containing borates or phosphates, rust removers, and button batteries.
Clinical Manifestations
Oropharyngeal findings may include pain, erythema, burns, erosions, ulcers, drooling, hoarseness, stridor, or aphonia; absence of visible lesions does not exclude severe visceral injury. Pulmonary involvement presents with cough, tachypnea, or aspiration pneumonitis. Gastrointestinal symptoms include chest or abdominal pain, dysphagia, odynophagia, emesis or hematemesis, melena, and signs of perforation or peritonitis. Cardiovascular findings include tachycardia and hypotension. Acid ingestion may cause hemolysis. Dermal exposure causes chemical burns, and ocular exposure ranges from conjunctival injection to full-thickness corneal injury. Metabolic acidosis may be present, particularly with acid ingestion.
Essential Initial Assessment
A clear history or signs of exposure are critical. Normal oropharyngeal examination does not rule out esophageal or gastric injury.
Diagnostic Evaluation
Laboratory testing includes CBC, electrolytes, BUN, creatinine, glucose, and arterial blood gas analysis. Blood cultures are indicated if mediastinitis or peritonitis is suspected. Type and cross-match should be obtained when bleeding is a concern. Chest and abdominal radiographs assess for perforation. Esophagogastroduodenoscopy is indicated in symptomatic patients to assess injury severity and should be performed within 12–24 hours, provided the airway is secure and there is no severe pharyngeal injury or respiratory distress. Acute contrast studies are not recommended but may be used later to evaluate strictures.
Key Alternative Diagnoses
Other chemical burns, foreign body ingestion, and upper airway infection or angioedema should be considered.
Prehospital Care
For oral exposure with mild symptoms, rinse the mouth with water or milk if the patient can swallow, has no vomiting, airway compromise, or significant abdominal pain. Copious irrigation is required for ocular or dermal exposure.
Emergency Stabilization
Airway protection is paramount; perform early intubation if respiratory compromise is present, avoiding blind nasotracheal intubation. Treat hypotension with isotonic IV fluids.
Emergency Department Management
Immediate irrigation of skin or eyes with water or normal saline should continue until physiologic pH is achieved, recognizing that alkali exposures require more prolonged irrigation. Induced emesis, activated charcoal, gastric lavage, and neutralizing agents are contraindicated. Limited dilution with water or milk may be considered within 30 minutes of ingestion if there is no airway compromise or suspected perforation; excessive volumes should be avoided. Keep patients NPO after oral exposure. Administer antiemetics and IV acid suppression for symptom control. Initiate broad-spectrum antibiotics if mediastinitis, peritonitis, or corticosteroid therapy is planned. Corticosteroid use to prevent esophageal strictures remains controversial and should be decided collaboratively; antibiotics are required if steroids are used. Surgical consultation is mandatory for suspected perforation or full-thickness necrosis. Hydrofluoric acid exposures require calcium therapy, including topical, intradermal, or intra-arterial calcium gluconate depending on severity and location.
Medications
Supportive medications may include ondansetron for nausea, IV proton pump inhibitors or H2 blockers for symptom relief, and corticosteroids only with multidisciplinary agreement. Calcium gluconate is essential for hydrofluoric acid injuries.
Disposition
All symptomatic patients and all nonaccidental ingestions require hospital admission. Asymptomatic patients with accidental ingestion who can swallow without difficulty and have no concerning findings may be discharged with instructions.
Follow-Up
Psychiatric evaluation is required for intentional ingestions.
Clinical Pearls
Early dilution with water or milk within 30 minutes may limit injury in select patients. Copious irrigation is essential for dermal and ocular exposures, particularly with alkalis. The absence of oral burns does not exclude severe internal injury.
Core Concept
Caustic ingestion causes chemical injury to tissues through acid or alkali exposure. Alkalis dissociate in water to form hydroxyl (OH⁻) ions, producing liquefaction necrosis that primarily damages the esophagus, though gastric injury can occur. Injury progresses from superficial hyperemia and mucosal edema to blistering, ulceration, full-thickness necrosis, perforation, and late fibrosis with esophageal strictures. Alkalis typically do not cause systemic toxicity.
Acids dissociate to form hydrogen (H⁺) ions, leading to coagulation necrosis with eschar formation. Due to rapid esophageal transit, acids mainly injure the stomach, producing edema, inflammation, hemorrhage, necrosis, perforation, and late gastric outlet obstruction. Acids are well absorbed and may cause hemolysis and systemic metabolic acidosis.
Etiologic Sources
Injuries result from direct chemical exposure to acids or alkalis, commonly found in household and industrial products. These include ammonia hydroxide, sodium hydroxide (drain and oven cleaners), sodium hypochlorite (bleach), sulfuric acid (car batteries), hydrochloric acid (toilet cleaners), hydrofluoric acid (glass etching and microchip industries), phenol, formaldehyde, iodine, detergents containing borates or phosphates, rust removers, and button batteries.
Clinical Manifestations
Oropharyngeal findings may include pain, erythema, burns, erosions, ulcers, drooling, hoarseness, stridor, or aphonia; absence of visible lesions does not exclude severe visceral injury. Pulmonary involvement presents with cough, tachypnea, or aspiration pneumonitis. Gastrointestinal symptoms include chest or abdominal pain, dysphagia, odynophagia, emesis or hematemesis, melena, and signs of perforation or peritonitis. Cardiovascular findings include tachycardia and hypotension. Acid ingestion may cause hemolysis. Dermal exposure causes chemical burns, and ocular exposure ranges from conjunctival injection to full-thickness corneal injury. Metabolic acidosis may be present, particularly with acid ingestion.
Essential Initial Assessment
A clear history or signs of exposure are critical. Normal oropharyngeal examination does not rule out esophageal or gastric injury.
Diagnostic Evaluation
Laboratory testing includes CBC, electrolytes, BUN, creatinine, glucose, and arterial blood gas analysis. Blood cultures are indicated if mediastinitis or peritonitis is suspected. Type and cross-match should be obtained when bleeding is a concern. Chest and abdominal radiographs assess for perforation. Esophagogastroduodenoscopy is indicated in symptomatic patients to assess injury severity and should be performed within 12–24 hours, provided the airway is secure and there is no severe pharyngeal injury or respiratory distress. Acute contrast studies are not recommended but may be used later to evaluate strictures.
Key Alternative Diagnoses
Other chemical burns, foreign body ingestion, and upper airway infection or angioedema should be considered.
Prehospital Care
For oral exposure with mild symptoms, rinse the mouth with water or milk if the patient can swallow, has no vomiting, airway compromise, or significant abdominal pain. Copious irrigation is required for ocular or dermal exposure.
Emergency Stabilization
Airway protection is paramount; perform early intubation if respiratory compromise is present, avoiding blind nasotracheal intubation. Treat hypotension with isotonic IV fluids.
Emergency Department Management
Immediate irrigation of skin or eyes with water or normal saline should continue until physiologic pH is achieved, recognizing that alkali exposures require more prolonged irrigation. Induced emesis, activated charcoal, gastric lavage, and neutralizing agents are contraindicated. Limited dilution with water or milk may be considered within 30 minutes of ingestion if there is no airway compromise or suspected perforation; excessive volumes should be avoided. Keep patients NPO after oral exposure. Administer antiemetics and IV acid suppression for symptom control. Initiate broad-spectrum antibiotics if mediastinitis, peritonitis, or corticosteroid therapy is planned. Corticosteroid use to prevent esophageal strictures remains controversial and should be decided collaboratively; antibiotics are required if steroids are used. Surgical consultation is mandatory for suspected perforation or full-thickness necrosis. Hydrofluoric acid exposures require calcium therapy, including topical, intradermal, or intra-arterial calcium gluconate depending on severity and location.
Medications
Supportive medications may include ondansetron for nausea, IV proton pump inhibitors or H2 blockers for symptom relief, and corticosteroids only with multidisciplinary agreement. Calcium gluconate is essential for hydrofluoric acid injuries.
Disposition
All symptomatic patients and all nonaccidental ingestions require hospital admission. Asymptomatic patients with accidental ingestion who can swallow without difficulty and have no concerning findings may be discharged with instructions.
Follow-Up
Psychiatric evaluation is required for intentional ingestions.
Clinical Pearls
Early dilution with water or milk within 30 minutes may limit injury in select patients. Copious irrigation is essential for dermal and ocular exposures, particularly with alkalis. The absence of oral burns does not exclude severe internal injury.
- Published on
Emergency and Acute Medicine – Carbon Monoxide Poisoning
Foundational Overview
Carbon monoxide is a colorless, odorless, and nonirritating gas that causes toxicity by binding hemoglobin to form carboxyhemoglobin, thereby reducing oxygen-carrying capacity. It also acts as a direct cellular toxin and interferes with intracellular oxygen utilization, leading to tissue hypoxia despite normal arterial oxygen tension.
Mechanisms And Sources
Carbon monoxide exposure may be endogenous at low levels from normal metabolism but is most often due to incomplete combustion of carbon-based fuels. Common sources include internal combustion engines, furnaces, fireplaces, heaters, indoor grills, accidental fires, and tobacco smoke. Methylene chloride, found in paint removers and furniture strippers, is metabolized in vivo to carbon monoxide, with delayed peak carboxyhemoglobin levels due to prolonged half-life.
Clinical Presentation
Symptoms are often nonspecific and may vary by organ system. Neurologic manifestations include headache, dizziness, ataxia, confusion, syncope, seizures, and coma. Gastrointestinal symptoms include nausea and vomiting. Cardiovascular findings may include chest pain and palpitations, while respiratory symptoms include dyspnea. Visual disturbances such as decreased acuity may occur.
Examination Findings
Neurologic examination may reveal acute encephalopathy, seizures, or coma. Cardiovascular findings include tachycardia, dysrhythmias, premature ventricular contractions, and myocardial ischemia or infarction. Respiratory findings include tachypnea and noncardiogenic pulmonary edema. Additional findings may include retinal hemorrhage, respiratory alkalosis, rhabdomyolysis, and lactic acidosis.
Initial Evaluation Strategy
A high index of suspicion is critical, as symptoms may be mild or vague. History should assess for similar symptoms in household members, malfunctioning heating systems, use of space heaters or ovens for heat, and illness in pets. Arterial blood gas typically shows normal PaO₂ with low measured oxygen saturation and may reveal metabolic acidosis in severe cases. Carboxyhemoglobin levels should be measured early but may underestimate severity if time has elapsed since exposure; normal levels are 0–3%, up to 10% in smokers.
Diagnostic Interpretation
Pulse oximetry is unreliable because it cannot differentiate oxyhemoglobin from carboxyhemoglobin and may appear falsely normal. Laboratory studies may reveal metabolic acidosis with elevated anion gap. Cardiac enzymes should be obtained when ischemia is suspected, and pregnancy testing is indicated when relevant. ECG may show dysrhythmias or nonspecific ST-T changes. Chest radiography may demonstrate pulmonary edema, and head CT may show bilateral globus pallidus lesions in unclear cases.
Conditions To Exclude
Alternative diagnoses include viral syndromes, meningitis or encephalitis, intracranial hemorrhage, gastroenteritis, migraine or tension headache, ethanol intoxication, sedative–hypnotic overdose, cyanide poisoning, salicylate toxicity, and toxic alcohol exposure.
Prehospital Care
Immediate administration of 100% oxygen is essential.
Early Emergency Management
Initial priorities include airway, breathing, and circulation, establishment of IV access, continuous cardiac monitoring, and delivery of 100% oxygen.
Definitive Emergency Treatment
Administer 100% normobaric oxygen via face mask or endotracheal tube until carboxyhemoglobin levels fall below 10%. The half-life of carboxyhemoglobin is approximately 300 minutes in room air, 90 minutes with 100% oxygen, and 20 minutes at 3 atmospheres in hyperbaric conditions. Hyperbaric oxygen therapy may reduce delayed neurologic sequelae and significantly shortens carboxyhemoglobin half-life, though its use remains controversial. Potential complications include barotrauma, pneumothorax, seizures, decompression sickness, and pulmonary edema. Consultation with a hyperbaric specialist is advised for altered mental status, focal neurologic deficits, seizures, cardiovascular instability, persistent metabolic acidosis, carboxyhemoglobin levels above 25%, or pregnancy with levels above 10%.
Pregnancy-Specific Considerations
Fetal hemoglobin has a higher affinity for carbon monoxide, resulting in fetal carboxyhemoglobin levels that exceed maternal levels by 10–15% and delayed fetal clearance, increasing risk of fetal hypoxia.
Disposition Planning
Admission is warranted for persistent symptoms after four hours of oxygen therapy, myocardial ischemia, seizures, syncope, metabolic acidosis, or hemodynamic instability. Discharge may be considered if the patient is asymptomatic after four hours of observation and none of the above criteria are present, with psychiatric clearance when exposure was intentional.
Follow-Up Guidance
Local fire authorities should be notified in cases of residential exposure to ensure environmental safety.
Key Clinical Insights
Carbon monoxide poisoning should be suspected in patients presenting with headache during heater use or when multiple individuals in the same environment develop similar symptoms. Early administration of 100% oxygen is critical, and timely transfer for hyperbaric therapy should be considered when indicated.
Foundational Overview
Carbon monoxide is a colorless, odorless, and nonirritating gas that causes toxicity by binding hemoglobin to form carboxyhemoglobin, thereby reducing oxygen-carrying capacity. It also acts as a direct cellular toxin and interferes with intracellular oxygen utilization, leading to tissue hypoxia despite normal arterial oxygen tension.
Mechanisms And Sources
Carbon monoxide exposure may be endogenous at low levels from normal metabolism but is most often due to incomplete combustion of carbon-based fuels. Common sources include internal combustion engines, furnaces, fireplaces, heaters, indoor grills, accidental fires, and tobacco smoke. Methylene chloride, found in paint removers and furniture strippers, is metabolized in vivo to carbon monoxide, with delayed peak carboxyhemoglobin levels due to prolonged half-life.
Clinical Presentation
Symptoms are often nonspecific and may vary by organ system. Neurologic manifestations include headache, dizziness, ataxia, confusion, syncope, seizures, and coma. Gastrointestinal symptoms include nausea and vomiting. Cardiovascular findings may include chest pain and palpitations, while respiratory symptoms include dyspnea. Visual disturbances such as decreased acuity may occur.
Examination Findings
Neurologic examination may reveal acute encephalopathy, seizures, or coma. Cardiovascular findings include tachycardia, dysrhythmias, premature ventricular contractions, and myocardial ischemia or infarction. Respiratory findings include tachypnea and noncardiogenic pulmonary edema. Additional findings may include retinal hemorrhage, respiratory alkalosis, rhabdomyolysis, and lactic acidosis.
Initial Evaluation Strategy
A high index of suspicion is critical, as symptoms may be mild or vague. History should assess for similar symptoms in household members, malfunctioning heating systems, use of space heaters or ovens for heat, and illness in pets. Arterial blood gas typically shows normal PaO₂ with low measured oxygen saturation and may reveal metabolic acidosis in severe cases. Carboxyhemoglobin levels should be measured early but may underestimate severity if time has elapsed since exposure; normal levels are 0–3%, up to 10% in smokers.
Diagnostic Interpretation
Pulse oximetry is unreliable because it cannot differentiate oxyhemoglobin from carboxyhemoglobin and may appear falsely normal. Laboratory studies may reveal metabolic acidosis with elevated anion gap. Cardiac enzymes should be obtained when ischemia is suspected, and pregnancy testing is indicated when relevant. ECG may show dysrhythmias or nonspecific ST-T changes. Chest radiography may demonstrate pulmonary edema, and head CT may show bilateral globus pallidus lesions in unclear cases.
Conditions To Exclude
Alternative diagnoses include viral syndromes, meningitis or encephalitis, intracranial hemorrhage, gastroenteritis, migraine or tension headache, ethanol intoxication, sedative–hypnotic overdose, cyanide poisoning, salicylate toxicity, and toxic alcohol exposure.
Prehospital Care
Immediate administration of 100% oxygen is essential.
Early Emergency Management
Initial priorities include airway, breathing, and circulation, establishment of IV access, continuous cardiac monitoring, and delivery of 100% oxygen.
Definitive Emergency Treatment
Administer 100% normobaric oxygen via face mask or endotracheal tube until carboxyhemoglobin levels fall below 10%. The half-life of carboxyhemoglobin is approximately 300 minutes in room air, 90 minutes with 100% oxygen, and 20 minutes at 3 atmospheres in hyperbaric conditions. Hyperbaric oxygen therapy may reduce delayed neurologic sequelae and significantly shortens carboxyhemoglobin half-life, though its use remains controversial. Potential complications include barotrauma, pneumothorax, seizures, decompression sickness, and pulmonary edema. Consultation with a hyperbaric specialist is advised for altered mental status, focal neurologic deficits, seizures, cardiovascular instability, persistent metabolic acidosis, carboxyhemoglobin levels above 25%, or pregnancy with levels above 10%.
Pregnancy-Specific Considerations
Fetal hemoglobin has a higher affinity for carbon monoxide, resulting in fetal carboxyhemoglobin levels that exceed maternal levels by 10–15% and delayed fetal clearance, increasing risk of fetal hypoxia.
Disposition Planning
Admission is warranted for persistent symptoms after four hours of oxygen therapy, myocardial ischemia, seizures, syncope, metabolic acidosis, or hemodynamic instability. Discharge may be considered if the patient is asymptomatic after four hours of observation and none of the above criteria are present, with psychiatric clearance when exposure was intentional.
Follow-Up Guidance
Local fire authorities should be notified in cases of residential exposure to ensure environmental safety.
Key Clinical Insights
Carbon monoxide poisoning should be suspected in patients presenting with headache during heater use or when multiple individuals in the same environment develop similar symptoms. Early administration of 100% oxygen is critical, and timely transfer for hyperbaric therapy should be considered when indicated.
- Published on
Emergency and Acute Medicine – Oral Candidiasis
Overview and Definitions
Oral candidiasis is an infection of the oral mucosa caused by species of Candida. Although Candida albicans accounts for up to 80% of cases, other species such as Candida glabrata and Candida tropicalis may be involved, particularly in immunocompromised patients. Candida organisms are part of the normal oral flora in approximately 60% of healthy individuals.
Clinical variants include pseudomembranous candidiasis (thrush), acute and chronic atrophic candidiasis, angular cheilitis, and hyperplastic candidiasis. The condition is more common in neonates, the elderly, and immunocompromised individuals. In otherwise healthy patients, oral candidiasis typically follows a benign, localized course. In immunocompromised patients, infections are more likely to be recurrent, caused by non-albicans species, and may represent an early manifestation of HIV infection. Although usually localized, certain populations are at risk for progression to systemic infection.
Etiology and Pathophysiology
Oral candidiasis most commonly results from overgrowth of Candida albicans due to alterations in the intraoral environment. Medication-induced changes are frequent, particularly with antimicrobial use, inhaled or systemic corticosteroids, chemotherapy, and immunosuppressive agents. Impaired immune function significantly increases susceptibility.
Reduced salivary flow also predisposes to infection and may occur with anticholinergic or psychotropic medications, Sjögren disease, or head and neck radiation. Denture use and orthodontic appliances are common contributing factors and account for a large proportion of chronic atrophic candidiasis cases. Disruption of the epithelial barrier, endocrinopathies such as diabetes or hypothyroidism, and mechanical trauma may also contribute.
In infants, immune immaturity and lack of established oral flora predispose to thrush. In the elderly, denture use and age-related changes increase colonization, and angular cheilitis is more common due to facial wrinkling.
Diagnosis
Signs and Symptoms
Pseudomembranous candidiasis presents with painless, white, adherent plaques that can be scraped off to reveal an erythematous base. Lesions may become confluent and curdlike and may be associated with anorexia or dysphagia.
Acute atrophic candidiasis presents as erythematous mucosa with a burning sensation, typically involving the palate or tongue, which may appear bright red. Chronic atrophic candidiasis, also known as denture stomatitis, causes irritation and erythema beneath dentures. Angular cheilitis presents as cracking, erythema, or pain at the corners of the mouth and is often complicated by bacterial superinfection. Hyperplastic candidiasis manifests as chronic, adherent plaques or ulcers, usually on the lateral tongue or buccal mucosa, and carries a risk of malignant transformation, especially in tobacco users.
Essential Workup
In otherwise healthy infants, minimal evaluation is required and diagnosis is usually clinical. In adults or older children without clear risk factors, evaluation for underlying immunodeficiency or diabetes should be considered. Systemic infection should be excluded in high-risk patients.
Diagnostic Tests and Interpretation
Diagnosis is most often clinical. Laboratory testing may include CBC and serum glucose in patients with suspected systemic disease. Fungal staining or culture may reveal branching hyphae or pseudohyphae and is recommended in refractory cases or high-risk patients such as those with HIV, neutropenia, or transplant history.
Differential Diagnosis
Hairy leukoplakia, lichen planus, squamous cell carcinoma, and adherent food or milk residue.
Management
Emergency Department Management
Supportive care includes IV fluids if dehydration is present and topical analgesia for pain control. “Magic mouthwash,” consisting of viscous lidocaine, antacid, and diphenhydramine, may provide symptomatic relief. Topical antifungal therapy is first-line treatment, while systemic therapy is reserved for severe, recurrent, or refractory disease.
Patient education regarding oral hygiene is essential, including rinsing the mouth after inhaled steroid use and proper denture care.
Medications
First-line therapy includes topical antifungals such as nystatin oral suspension, nystatin pastilles, or clotrimazole troches administered for 7–14 days. Second-line therapy includes systemic azoles such as fluconazole or itraconazole for patients who fail topical therapy or have severe disease. Amphotericin B is preferred during pregnancy when systemic therapy is required.
Disposition and Follow-Up
Patients may be discharged if hydration and oral intake are adequate. Admission is indicated for inability to tolerate oral intake, newly diagnosed immunocompromised states, or evidence of systemic infection. Persistent or unexplained oral candidiasis warrants further evaluation for immunodeficiency.
Clinical Pearls and Pitfalls
Failure to recognize underlying immunodeficiency can delay diagnosis of serious systemic illness. Persistent oral lesions should prompt evaluation for alternative diagnoses, including squamous cell carcinoma.
- Published on
Emergency and Acute Medicine – Carbamazepine Poisoning
Overview And Clinical Context
Carbamazepine is an anticonvulsant used for seizure disorders, chronic neuropathic pain, migraine prophylaxis, and mood stabilization. Toxicity most commonly results from intentional overdose but may also occur with accidental ingestion, supratherapeutic dosing, or drug–drug interactions. Extended-release formulations are associated with delayed and unpredictable absorption. The drug blocks voltage-gated sodium channels and has anticholinergic properties similar to phenytoin and tricyclic antidepressants, leading primarily to neurologic toxicity, with cardiotoxicity typically seen only in massive overdoses.
Pathophysiology And Toxic Mechanisms
Excessive sodium channel blockade impairs neuronal conduction and decreases synaptic transmission. Carbamazepine is metabolized hepatically to an active epoxide metabolite that contributes significantly to toxicity but is not routinely measured, explaining the poor correlation between serum levels and clinical severity. Erratic gastrointestinal absorption and enterohepatic recirculation result in fluctuating serum concentrations and delayed recurrence of symptoms.
Clinical Manifestations
Neurologic findings predominate and include dizziness, drowsiness, ataxia, nystagmus, agitation, hallucinations, coma, and seizures. Respiratory depression and aspiration pneumonia may occur in severe cases. Cardiovascular effects include hypotension and conduction abnormalities, particularly in elderly patients or massive ingestions. Sinus tachycardia or bradycardia may be present, with ECG findings of PR, QRS, and QTc prolongation and nonspecific T-wave changes. Anticholinergic features include mydriasis, flushing, urinary retention, and decreased bowel sounds, while neuromuscular findings may include tremor, slurred speech, myoclonus, and choreiform movements.
Initial Assessment Priorities
All symptomatic patients require continuous cardiac monitoring. Serum carbamazepine levels should be obtained, recognizing therapeutic concentrations of 6–12 μg/mL and that levels above 25–40 μg/mL are associated with severe toxicity. Because serum levels may not reflect CNS exposure, serial measurements are often required. Electrocardiography is essential to assess conduction delays, and serum acetaminophen levels should be obtained in suspected intentional ingestions to evaluate for coingestants.
Supporting Diagnostic Studies
Laboratory findings may include leukopenia or leukocytosis, hyponatremia, hypokalemia, hyperglycemia, and mild transaminase elevations. Arterial blood gas analysis may show respiratory acidosis in severe poisoning. Urinalysis may demonstrate glucosuria or ketonuria. Chest radiography is indicated when aspiration pneumonia or pulmonary edema is suspected.
Diagnostic Alternatives To Consider
The differential diagnosis includes alcohol, benzodiazepines, opioids, lithium, barbiturates, anticholinergics, and phenothiazines. Seizure etiologies include alcohol withdrawal, isoniazid, camphor, sympathomimetics, and tricyclic antidepressants. Abnormal movements may be caused by antihistamines, cocaine, phenytoin, caffeine, neuroleptics, or levodopa.
Early Stabilization Measures
Ipecac is contraindicated. Initial management follows airway, breathing, and circulation principles with early airway protection for respiratory depression. Supplemental oxygen, intravenous access, isotonic fluid resuscitation for hypotension, and continuous cardiac monitoring are required. Naloxone, thiamine, and glucose should be considered in patients with altered mental status.
Emergency Department Management
Activated charcoal is recommended if presentation is early and bowel sounds are present, with sorbitol used only in the initial dose. Multidose activated charcoal may reduce toxicity by interrupting enterohepatic circulation and is indicated in moderate to severe cases. Hemoperfusion or hemodialysis removes limited drug amounts and is reserved for clinical deterioration despite supportive care. Respiratory failure requires intubation and ventilatory support. Hypotension should be treated with isotonic crystalloid boluses followed by norepinephrine if refractory. Seizures are treated with benzodiazepines, with diazepam as first-line therapy, and phenobarbital if refractory. Phenytoin is ineffective. Sodium bicarbonate is indicated for significant QRS prolongation. Psychiatric consultation is mandatory after intentional ingestion.
Disposition And Follow-Up Planning
Patients with seizures, dysrhythmias, persistent altered mental status, or intentional overdose require admission and monitoring for at least 24 hours due to delayed toxicity and serum level rebound. Asymptomatic patients may be discharged after six hours of observation if mental status and ECG are normal and psychiatric clearance is obtained when indicated.
High-Yield Clinical Takeaways
Carbamazepine levels commonly rebound, requiring serial monitoring. Clinical toxicity correlates poorly with serum concentrations. Multidose activated charcoal is frequently necessary. Paradoxical seizures may occur and should be treated with benzodiazepines. Continuous cardiac monitoring is essential due to delayed conduction abnormalities.
.
Overview And Clinical Context
Carbamazepine is an anticonvulsant used for seizure disorders, chronic neuropathic pain, migraine prophylaxis, and mood stabilization. Toxicity most commonly results from intentional overdose but may also occur with accidental ingestion, supratherapeutic dosing, or drug–drug interactions. Extended-release formulations are associated with delayed and unpredictable absorption. The drug blocks voltage-gated sodium channels and has anticholinergic properties similar to phenytoin and tricyclic antidepressants, leading primarily to neurologic toxicity, with cardiotoxicity typically seen only in massive overdoses.
Pathophysiology And Toxic Mechanisms
Excessive sodium channel blockade impairs neuronal conduction and decreases synaptic transmission. Carbamazepine is metabolized hepatically to an active epoxide metabolite that contributes significantly to toxicity but is not routinely measured, explaining the poor correlation between serum levels and clinical severity. Erratic gastrointestinal absorption and enterohepatic recirculation result in fluctuating serum concentrations and delayed recurrence of symptoms.
Clinical Manifestations
Neurologic findings predominate and include dizziness, drowsiness, ataxia, nystagmus, agitation, hallucinations, coma, and seizures. Respiratory depression and aspiration pneumonia may occur in severe cases. Cardiovascular effects include hypotension and conduction abnormalities, particularly in elderly patients or massive ingestions. Sinus tachycardia or bradycardia may be present, with ECG findings of PR, QRS, and QTc prolongation and nonspecific T-wave changes. Anticholinergic features include mydriasis, flushing, urinary retention, and decreased bowel sounds, while neuromuscular findings may include tremor, slurred speech, myoclonus, and choreiform movements.
Initial Assessment Priorities
All symptomatic patients require continuous cardiac monitoring. Serum carbamazepine levels should be obtained, recognizing therapeutic concentrations of 6–12 μg/mL and that levels above 25–40 μg/mL are associated with severe toxicity. Because serum levels may not reflect CNS exposure, serial measurements are often required. Electrocardiography is essential to assess conduction delays, and serum acetaminophen levels should be obtained in suspected intentional ingestions to evaluate for coingestants.
Supporting Diagnostic Studies
Laboratory findings may include leukopenia or leukocytosis, hyponatremia, hypokalemia, hyperglycemia, and mild transaminase elevations. Arterial blood gas analysis may show respiratory acidosis in severe poisoning. Urinalysis may demonstrate glucosuria or ketonuria. Chest radiography is indicated when aspiration pneumonia or pulmonary edema is suspected.
Diagnostic Alternatives To Consider
The differential diagnosis includes alcohol, benzodiazepines, opioids, lithium, barbiturates, anticholinergics, and phenothiazines. Seizure etiologies include alcohol withdrawal, isoniazid, camphor, sympathomimetics, and tricyclic antidepressants. Abnormal movements may be caused by antihistamines, cocaine, phenytoin, caffeine, neuroleptics, or levodopa.
Early Stabilization Measures
Ipecac is contraindicated. Initial management follows airway, breathing, and circulation principles with early airway protection for respiratory depression. Supplemental oxygen, intravenous access, isotonic fluid resuscitation for hypotension, and continuous cardiac monitoring are required. Naloxone, thiamine, and glucose should be considered in patients with altered mental status.
Emergency Department Management
Activated charcoal is recommended if presentation is early and bowel sounds are present, with sorbitol used only in the initial dose. Multidose activated charcoal may reduce toxicity by interrupting enterohepatic circulation and is indicated in moderate to severe cases. Hemoperfusion or hemodialysis removes limited drug amounts and is reserved for clinical deterioration despite supportive care. Respiratory failure requires intubation and ventilatory support. Hypotension should be treated with isotonic crystalloid boluses followed by norepinephrine if refractory. Seizures are treated with benzodiazepines, with diazepam as first-line therapy, and phenobarbital if refractory. Phenytoin is ineffective. Sodium bicarbonate is indicated for significant QRS prolongation. Psychiatric consultation is mandatory after intentional ingestion.
Disposition And Follow-Up Planning
Patients with seizures, dysrhythmias, persistent altered mental status, or intentional overdose require admission and monitoring for at least 24 hours due to delayed toxicity and serum level rebound. Asymptomatic patients may be discharged after six hours of observation if mental status and ECG are normal and psychiatric clearance is obtained when indicated.
High-Yield Clinical Takeaways
Carbamazepine levels commonly rebound, requiring serial monitoring. Clinical toxicity correlates poorly with serum concentrations. Multidose activated charcoal is frequently necessary. Paradoxical seizures may occur and should be treated with benzodiazepines. Continuous cardiac monitoring is essential due to delayed conduction abnormalities.
.
- Published on
Emergency and Acute Medicine – Cardiac Arrest
Critical Update Notice
This summary reflects principles derived from the 2010 ACLS guidelines. Key updates emphasized early chest compressions with a C–A–B sequence, greater focus on post–cardiac arrest care including targeted temperature management, and removal of atropine from PEA/asystole algorithms.
Clinical Overview
Sudden cardiac arrest is defined by unresponsiveness, absence of a palpable pulse, and minimal or absent respirations. Survival is influenced by the presenting rhythm, total downtime, speed of defibrillation when indicated, and early initiation of high-quality basic life support.
Underlying Causes
Reversible contributors are commonly recalled as the “Hs and Ts”: hypovolemia, hypoxia, hydrogen ion excess (acidosis), hypo- or hyperkalemia, hypothermia, toxins, cardiac tamponade, tension pneumothorax, thrombosis (coronary or pulmonary), and trauma.
Special Populations
In children, arrest is more often secondary to respiratory failure rather than primary cardiac causes. Pediatric resuscitation requires shallower compressions (approximately one-third to one-half of chest depth), a 15:2 compression-to-ventilation ratio for two rescuers, and weight-based medication dosing.
In pregnancy, airway management may be difficult, compressions should be performed slightly higher on the sternum, and manual left uterine displacement should be used. Maternal survival remains the priority; emergent cesarean delivery may be considered if maternal resuscitation fails.
Clinical Recognition
Patients present with sudden loss of responsiveness, pulselessness, and agonal or absent respirations. Arrest may be preceded by chest pain, dyspnea, palpitations, seizure-like activity, hypotension, or altered mental status.
Immediate Assessment
Rapidly assess airway, breathing, and circulation, determine whether the rhythm is shockable or nonshockable, and initiate treatment according to ACLS algorithms without delay.
Diagnostic Evaluation After ROSC
Laboratory testing is indicated only after return of spontaneous circulation and may include electrolytes, renal function, cardiac biomarkers, arterial blood gas, CBC, lactate, therapeutic drug levels, and toxicology screening. ECG should assess for STEMI or acute coronary syndrome. Chest radiography confirms airway placement and evaluates for pulmonary causes. Echocardiography may identify tamponade or wall-motion abnormalities. Head CT may be required postresuscitation to evaluate neurologic causes.
Conditions To Exclude
Alternative causes of sudden collapse with a pulse include syncope, seizure, stroke, hypoglycemia, airway obstruction, head trauma, and toxic exposures.
Prehospital Management
Begin immediate high-quality CPR, confirm rhythm, and defibrillate pulseless VT or VF as early as possible. Secure the airway only if it does not interrupt compressions. After ROSC, stabilize blood pressure, obtain a 12-lead ECG, and transport to a facility capable of advanced postarrest and interventional cardiac care.
Early In-Hospital Resuscitation
Initiate ACLS with uninterrupted CPR, brief rhythm and pulse checks, early defibrillation when indicated, IV or IO access, continuous cardiac monitoring, and rhythm-directed therapy.
Definitive Emergency Treatment
For pulseless VT/VF, perform immediate defibrillation followed by CPR, epinephrine, and antiarrhythmics such as amiodarone or lidocaine; magnesium is used for torsades de pointes.
For asystole and pulseless electrical activity, confirm rhythm, administer epinephrine, and aggressively search for and correct reversible causes.
After ROSC, address the underlying etiology, provide ventilatory and hemodynamic support, correct metabolic abnormalities, evaluate for coronary ischemia with early catheterization when appropriate, initiate targeted temperature management in eligible patients, and monitor for seizures with continuous EEG when indicated.
Pharmacologic Support
Medications commonly used include epinephrine, amiodarone, lidocaine, magnesium sulfate, vasopressin (as an epinephrine substitute in adults), and sodium bicarbonate in select circumstances. Drug delivery should never interrupt CPR.
Disposition Planning
All patients with ROSC require ICU admission for comprehensive postarrest care and management of the precipitating cause. There are no discharge criteria directly from the arrest setting.
Follow-Up And Systems Care
Postarrest patients benefit from admission to intensive care units experienced in targeted temperature management and advanced cardiac support. Referral to regional cardiac arrest centers may improve outcomes.
Clinical Pearls And Pitfalls
Targeted temperature management improves neurologic outcomes in comatose postarrest patients. Recurrent arrest is common, requiring vigilant monitoring and rapid intervention. Early cardiology consultation is essential to determine candidacy for urgent cardiac catheterization.
Critical Update Notice
This summary reflects principles derived from the 2010 ACLS guidelines. Key updates emphasized early chest compressions with a C–A–B sequence, greater focus on post–cardiac arrest care including targeted temperature management, and removal of atropine from PEA/asystole algorithms.
Clinical Overview
Sudden cardiac arrest is defined by unresponsiveness, absence of a palpable pulse, and minimal or absent respirations. Survival is influenced by the presenting rhythm, total downtime, speed of defibrillation when indicated, and early initiation of high-quality basic life support.
Underlying Causes
Reversible contributors are commonly recalled as the “Hs and Ts”: hypovolemia, hypoxia, hydrogen ion excess (acidosis), hypo- or hyperkalemia, hypothermia, toxins, cardiac tamponade, tension pneumothorax, thrombosis (coronary or pulmonary), and trauma.
Special Populations
In children, arrest is more often secondary to respiratory failure rather than primary cardiac causes. Pediatric resuscitation requires shallower compressions (approximately one-third to one-half of chest depth), a 15:2 compression-to-ventilation ratio for two rescuers, and weight-based medication dosing.
In pregnancy, airway management may be difficult, compressions should be performed slightly higher on the sternum, and manual left uterine displacement should be used. Maternal survival remains the priority; emergent cesarean delivery may be considered if maternal resuscitation fails.
Clinical Recognition
Patients present with sudden loss of responsiveness, pulselessness, and agonal or absent respirations. Arrest may be preceded by chest pain, dyspnea, palpitations, seizure-like activity, hypotension, or altered mental status.
Immediate Assessment
Rapidly assess airway, breathing, and circulation, determine whether the rhythm is shockable or nonshockable, and initiate treatment according to ACLS algorithms without delay.
Diagnostic Evaluation After ROSC
Laboratory testing is indicated only after return of spontaneous circulation and may include electrolytes, renal function, cardiac biomarkers, arterial blood gas, CBC, lactate, therapeutic drug levels, and toxicology screening. ECG should assess for STEMI or acute coronary syndrome. Chest radiography confirms airway placement and evaluates for pulmonary causes. Echocardiography may identify tamponade or wall-motion abnormalities. Head CT may be required postresuscitation to evaluate neurologic causes.
Conditions To Exclude
Alternative causes of sudden collapse with a pulse include syncope, seizure, stroke, hypoglycemia, airway obstruction, head trauma, and toxic exposures.
Prehospital Management
Begin immediate high-quality CPR, confirm rhythm, and defibrillate pulseless VT or VF as early as possible. Secure the airway only if it does not interrupt compressions. After ROSC, stabilize blood pressure, obtain a 12-lead ECG, and transport to a facility capable of advanced postarrest and interventional cardiac care.
Early In-Hospital Resuscitation
Initiate ACLS with uninterrupted CPR, brief rhythm and pulse checks, early defibrillation when indicated, IV or IO access, continuous cardiac monitoring, and rhythm-directed therapy.
Definitive Emergency Treatment
For pulseless VT/VF, perform immediate defibrillation followed by CPR, epinephrine, and antiarrhythmics such as amiodarone or lidocaine; magnesium is used for torsades de pointes.
For asystole and pulseless electrical activity, confirm rhythm, administer epinephrine, and aggressively search for and correct reversible causes.
After ROSC, address the underlying etiology, provide ventilatory and hemodynamic support, correct metabolic abnormalities, evaluate for coronary ischemia with early catheterization when appropriate, initiate targeted temperature management in eligible patients, and monitor for seizures with continuous EEG when indicated.
Pharmacologic Support
Medications commonly used include epinephrine, amiodarone, lidocaine, magnesium sulfate, vasopressin (as an epinephrine substitute in adults), and sodium bicarbonate in select circumstances. Drug delivery should never interrupt CPR.
Disposition Planning
All patients with ROSC require ICU admission for comprehensive postarrest care and management of the precipitating cause. There are no discharge criteria directly from the arrest setting.
Follow-Up And Systems Care
Postarrest patients benefit from admission to intensive care units experienced in targeted temperature management and advanced cardiac support. Referral to regional cardiac arrest centers may improve outcomes.
Clinical Pearls And Pitfalls
Targeted temperature management improves neurologic outcomes in comatose postarrest patients. Recurrent arrest is common, requiring vigilant monitoring and rapid intervention. Early cardiology consultation is essential to determine candidacy for urgent cardiac catheterization.
- Published on
Emergency and Acute Medicine – Cauda Equina Syndrome
Core Concept
Cauda equina syndrome results from compression of the lumbar and sacral nerve roots within the cauda equina, which consists of nerve fibers below the conus medullaris, typically ending at the L1–L2 interspace. This condition represents a neurologic emergency because delayed diagnosis and treatment can lead to permanent deficits.
Predisposing Factors
Patients at increased risk include those with neoplastic disease, intravenous drug use, immunocompromised states, and a history of trauma.
Underlying Causes
Lumbar disc herniation is the most common etiology, most frequently involving the L4–L5 level, followed by L5–S1 and L3–L4, and is most often seen in the fourth and fifth decades of life. Other causes include mass lesions such as myeloma, lymphoma, sarcoma, meningioma, neurofibroma, hematoma, and metastatic disease from breast, lung, prostate, thyroid, or renal malignancies. Infectious causes include spinal epidural abscess, particularly in IV drug users. Additional etiologies include blunt or penetrating trauma, complications of spinal anesthesia, and postoperative or spontaneous hematoma.
Clinical Manifestations
Patients commonly report low back pain with unilateral or bilateral radicular symptoms, lower-extremity numbness or weakness, and difficulty ambulating due to pain or motor deficits. Bladder or bowel dysfunction is a key feature and may present as urinary retention, overflow incontinence, or fecal incontinence. On examination, lumbosacral tenderness may be present along with asymmetric lower-extremity sensory or motor deficits, reduced dorsiflexion strength, quadriceps weakness, diminished deep tendon reflexes, saddle hypalgesia or anesthesia, and decreased anal sphincter tone.
Essential Bedside Assessment
A thorough neurologic examination is critical and includes straight-leg raise testing and the Lasègue maneuver, where hip flexion with foot dorsiflexion reproduces posterior thigh pain. Evaluation of perineal sensation, rectal tone, and the anal wink reflex is essential. Measurement of postvoid residual volume by bladder catheterization or ultrasound is strongly recommended, with volumes greater than 50–100 mL considered abnormal, recognizing that residual volume increases with age; a normal residual makes the diagnosis less likely.
Diagnostic Evaluation
Laboratory testing is guided by the suspected differential and may include CBC, urinalysis, ESR, and CRP, particularly when infection or malignancy is a concern. MRI of the spine is the definitive diagnostic study and should be obtained urgently. If MRI is unavailable or contraindicated, CT myelography is an acceptable alternative. Plain radiographs of the lumbosacral spine may be obtained but are insufficient to exclude the diagnosis.
Key Alternative Diagnoses
Conditions that may mimic cauda equina syndrome include lumbosacral strain, osteoarthritis, sciatica, vertebral fractures, osteomyelitis, spinal epidural abscess, conus medullaris or higher spinal cord compression, ankylosing spondylitis, spinal stenosis, abdominal aortic aneurysm or dissection, vascular claudication, hip pathology, and acute transverse myelitis.
Initial Management Priorities
Airway and other traumatic injuries should be managed as indicated. In trauma patients, full spinal immobilization is mandatory, and even in nontrauma presentations, immobilization should be considered because of the possibility of an unstable spinal lesion. Provide adequate analgesia and keep the patient NPO pending neurosurgical evaluation.
Emergency Department Management
Serial neurologic examinations are required to identify progression. Immediate neurosurgical consultation is mandatory in all suspected cases. For acute spinal cord trauma within 8 hours of onset, initiate high-dose methylprednisolone per protocol. If an epidural abscess is suspected, start empiric antibiotics in consultation with neurosurgery. Although there is debate regarding the exact timing of surgical decompression, recommendations generally range from within 6 hours to within 24 hours of symptom onset, with earlier intervention associated with better outcomes.
Pharmacologic Therapy
High-dose methylprednisolone may be administered for acute spinal cord injury using a protocol of a 30 mg/kg IV bolus followed by a continuous infusion of 5.4 mg/kg/hr over 23 hours, provided therapy is initiated within 8 hours of injury.
Disposition and Follow-Up
All patients with acute cauda equina syndrome require hospital admission under neurosurgical care, and treatment should not be delayed. Rapid surgical decompression is associated with improved neurologic recovery, although patients presenting later than 48 hours may still derive benefit. Discharge is appropriate only for patients with a prior complete evaluation, established diagnosis, no new neurologic deficits, and close follow-up arranged with their neurosurgeon.
Clinical Insights and Cautions
Early recognition before irreversible neurologic injury is crucial. Red flags include back pain disproportionate to exam findings, back pain with fever, and back pain in high-risk populations. When infection is suspected, ESR and CRP should be used as screening tools to avoid missed diagnoses.
Core Concept
Cauda equina syndrome results from compression of the lumbar and sacral nerve roots within the cauda equina, which consists of nerve fibers below the conus medullaris, typically ending at the L1–L2 interspace. This condition represents a neurologic emergency because delayed diagnosis and treatment can lead to permanent deficits.
Predisposing Factors
Patients at increased risk include those with neoplastic disease, intravenous drug use, immunocompromised states, and a history of trauma.
Underlying Causes
Lumbar disc herniation is the most common etiology, most frequently involving the L4–L5 level, followed by L5–S1 and L3–L4, and is most often seen in the fourth and fifth decades of life. Other causes include mass lesions such as myeloma, lymphoma, sarcoma, meningioma, neurofibroma, hematoma, and metastatic disease from breast, lung, prostate, thyroid, or renal malignancies. Infectious causes include spinal epidural abscess, particularly in IV drug users. Additional etiologies include blunt or penetrating trauma, complications of spinal anesthesia, and postoperative or spontaneous hematoma.
Clinical Manifestations
Patients commonly report low back pain with unilateral or bilateral radicular symptoms, lower-extremity numbness or weakness, and difficulty ambulating due to pain or motor deficits. Bladder or bowel dysfunction is a key feature and may present as urinary retention, overflow incontinence, or fecal incontinence. On examination, lumbosacral tenderness may be present along with asymmetric lower-extremity sensory or motor deficits, reduced dorsiflexion strength, quadriceps weakness, diminished deep tendon reflexes, saddle hypalgesia or anesthesia, and decreased anal sphincter tone.
Essential Bedside Assessment
A thorough neurologic examination is critical and includes straight-leg raise testing and the Lasègue maneuver, where hip flexion with foot dorsiflexion reproduces posterior thigh pain. Evaluation of perineal sensation, rectal tone, and the anal wink reflex is essential. Measurement of postvoid residual volume by bladder catheterization or ultrasound is strongly recommended, with volumes greater than 50–100 mL considered abnormal, recognizing that residual volume increases with age; a normal residual makes the diagnosis less likely.
Diagnostic Evaluation
Laboratory testing is guided by the suspected differential and may include CBC, urinalysis, ESR, and CRP, particularly when infection or malignancy is a concern. MRI of the spine is the definitive diagnostic study and should be obtained urgently. If MRI is unavailable or contraindicated, CT myelography is an acceptable alternative. Plain radiographs of the lumbosacral spine may be obtained but are insufficient to exclude the diagnosis.
Key Alternative Diagnoses
Conditions that may mimic cauda equina syndrome include lumbosacral strain, osteoarthritis, sciatica, vertebral fractures, osteomyelitis, spinal epidural abscess, conus medullaris or higher spinal cord compression, ankylosing spondylitis, spinal stenosis, abdominal aortic aneurysm or dissection, vascular claudication, hip pathology, and acute transverse myelitis.
Initial Management Priorities
Airway and other traumatic injuries should be managed as indicated. In trauma patients, full spinal immobilization is mandatory, and even in nontrauma presentations, immobilization should be considered because of the possibility of an unstable spinal lesion. Provide adequate analgesia and keep the patient NPO pending neurosurgical evaluation.
Emergency Department Management
Serial neurologic examinations are required to identify progression. Immediate neurosurgical consultation is mandatory in all suspected cases. For acute spinal cord trauma within 8 hours of onset, initiate high-dose methylprednisolone per protocol. If an epidural abscess is suspected, start empiric antibiotics in consultation with neurosurgery. Although there is debate regarding the exact timing of surgical decompression, recommendations generally range from within 6 hours to within 24 hours of symptom onset, with earlier intervention associated with better outcomes.
Pharmacologic Therapy
High-dose methylprednisolone may be administered for acute spinal cord injury using a protocol of a 30 mg/kg IV bolus followed by a continuous infusion of 5.4 mg/kg/hr over 23 hours, provided therapy is initiated within 8 hours of injury.
Disposition and Follow-Up
All patients with acute cauda equina syndrome require hospital admission under neurosurgical care, and treatment should not be delayed. Rapid surgical decompression is associated with improved neurologic recovery, although patients presenting later than 48 hours may still derive benefit. Discharge is appropriate only for patients with a prior complete evaluation, established diagnosis, no new neurologic deficits, and close follow-up arranged with their neurosurgeon.
Clinical Insights and Cautions
Early recognition before irreversible neurologic injury is crucial. Red flags include back pain disproportionate to exam findings, back pain with fever, and back pain in high-risk populations. When infection is suspected, ESR and CRP should be used as screening tools to avoid missed diagnoses.
